Lisa J. Redman has more than 25 years of finance and accounting experience. Ms. Redman is our Vice President, Finance.
Previously, Ms. Redman was head of finance for MB2 during its purchase of Marcadia Biotech and its acquisition by Novo Nordisk. She has served in key finance roles in numerous biotechnology companies including Crinetics Pharmaceuticals and Auspex Pharmaceuticals where she was integrally involved with their IPO preparations. Further, Ms. Redman also helped companies with SEC reporting, Sarbanes-Oxley implementations and grant compliances.
Ms. Redman was a CFO of a publicly held technology company and a controller of several venture-backed companies in a variety of industries including medical devices, food distribution and mortgage banking. She began her career as an auditor for Coopers & Lybrand (now PWC) where she served both public and private companies. Ms. Redman holds a bachelor’s degree in Business Administration from San Diego State University. She is a Certified Public Accountant in the State of California (on inactive status).